Target intelligence / Profile preview

ARHGAP29 antisense RNA 1 (ARHGAP29-AS1)

Target: ARHGAP29-AS1
Molecular classification: Long non-coding RNA (lncRNA)

Overview

ARHGAP29 antisense RNA 1 (ARHGAP29-AS1) is a human long non-coding RNA (lncRNA) gene located on chromosome 1. It is transcribed antisense to the protein-coding gene ARHGAP29, meaning its RNA is produced from the opposite DNA strand and overlaps the ARHGAP29 gene. As a member of the lncRNA class, ARHGAP29-AS1 does not encode a protein and its precise biological function is not well characterized. By analogy with other antisense lncRNAs, it may be involved in epigenetic or transcriptional regulation of its sense gene (ARHGAP29), but direct evidence for this or involvement in disease processes is lacking. There is no evidence that ARHGAP29-AS1 is currently considered a drug target, nor is it a well-validated biomarker or linked to any known pharmacological mechanism.

Other names: ARHGAP29 antisense RNA 1ARHGAP29-AS1

Mechanism of action

Not applicable; no drugs are known to target ARHGAP29-AS1 directly.

Biological functions

Not definitively established; as an lncRNA, it likely acts at the RNA level to regulate the expression of its sense gene (ARHGAP29) or neighboring genes

Disease associations

There is currently no direct evidence that ARHGAP29-AS1 itself is a disease driver or biomarker, nor is it directly implicated in specific pathologies distinct from its parental gene ARHGAP29

Beyond the preview

Go deeper on ARHGAP29 antisense RNA 1 (ARHGAP29-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ARHGAP29 antisense RNA 1 (ARHGAP29-AS1).

Explore the full profile